Botox Maker Settles Case for $600 Million

Botox Maker Settles Case for $600 Million
New York Times Blog
September 1, 2010

The New York Times was one of the first national publications to report on the $600 million settlement of Nolan Auerbach’s qui tam case against Allergan. “The significance of the case is that Allergan promoted Botox for off-label uses, uses that were not approved by the FDA as being safe and effective,” said Marcella Auerbach, managing partner of Nolan Auerbach.

OUR PROMISE Being a healthcare whistleblower can feel like David taking on Goliath. We help level the playing field.

Our law practice is dedicated exclusively to representing healthcare whistleblowers who are willing to take a stand against unscrupulous corporations that are ripping off our government. Whether the fraud involves __________, we pride ourselves on unparalleled level of service, support and legal assistance for our clients.
Contact Us

Contact Us

The more detailed the response, the more likely it is that we will be able to evaluate and determine if your potential False Claims Act case falls within our case requirements. If it does, WE WILL RESPOND TO YOU WITHIN 24 HOURS. (Names of potential defendants are not necessary at this point, should you feel more comfortable omitting them.) By law, all communications to us are 100% confidential.

Please enable JavaScript in your browser to complete this form.
No. of Employees at the Company?


Please read the following statement and then click “Send Form”:

Any response to your e-mail will be solely to communicate about our possible representation of you under the qui tam provisions of the False Claims Act. All e-mails submitted to us, whether we take your case or not, are 100% confidential. If we do not respond to your e-mail, then you have communicated information which we cannot address because it appears to fall outside of the False Claims Act or our case requirements.